We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Regeneron’s Antibody Cocktail for Ebola Virus
FDA Approves Regeneron’s Antibody Cocktail for Ebola Virus
The FDA has approved Regeneron Pharmaceuticals’ Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn), a combination of three monoclonal antibodies, making it the agency’s first approved treatment for the Ebola virus.